-+ 0.00%
-+ 0.00%
-+ 0.00%
815MNB to Showcase Neuraon Assist Wellness Headband at CES 2027
Share
Listen to the news

815MNB, a South Korean wearable health-tech company (CEO Yongwon Choi), announced today that it will showcase its flagship wellness headband, Neuraon Assist, at CES 2027 in Las Vegas. Designed for modern individuals who struggle to unwind during hectic days or find themselves physically exhausted yet wide awake at bedtime, the device offers an effortless approach to daily stress relief and sleep preparation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261119851148/en/

815MNB’s Neuraon Assist wellness headband (Image: 815MNB)

815MNB’s Neuraon Assist wellness headband (Image: 815MNB)

William Marcel Sauve, Chief Technology Officer (CTO) at 815MNB, said, "Conventional wearable devices and stress scores can show people how their day has affected them, yet they still leave users to figure out what to do next." He added, "Neuraon Assist was born out of that familiar frustration. Instead of adding another layer of data to analyze, it eases that burden by automatically adjusting stimulation while the wearer simply takes a break."

At the core of Neuraon Assist is a proprietary closed-loop biofeedback system. The lightweight headband continuously tracks the user’s heart rate and heart rate variability (HRV), compares the readings against their personal baseline patterns, and delivers gentle, personalized noninvasive vagus nerve stimulation (VNS). It then measures the wearer’s real-time physiological response to dynamically guide the next adjustment. This automated process allows users to rest deeply without having to interpret complicated charts, interact with smartphone apps, or manually change settings throughout a session.

Alongside its growing consumer wellness business, 815MNB is actively expanding its research and development pipeline into specialized therapeutic applications. Current research initiatives explore potential interventions for developmental disabilities, cognitive health in older adults, post-traumatic stress disorder (PTSD), and behavioral or substance addictions involving gambling, drugs, or alcohol. The company expects to begin launching commercial products stemming from this clinical research in 2028.

About 815MNB

815MNB is a South Korean wearable technology innovator dedicated to developing closed-loop, bio-signal-based wellness and therapeutic solutions. By bridging real-time physiological monitoring with noninvasive neuromodulation, 815MNB aims to improve daily relaxation, restorative sleep, and long-term cognitive well-being. For more information, please visit www.815mnb.com.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending